Infections caused by non-tuberculous mycobacteria (NTM) are increasing globally and are
notoriously difficult to treat due to intrinsic resistance of these bacteria to many common …

Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Nontuberculous mycobacteria (NTM) are emerging human pathogens, causing a wide
range of clinical diseases affecting individuals who are immunocompromised and who have …

Lung infections with Mycobacterium abscessus, a species of multidrug-resistant
nontuberculous mycobacteria, are emerging as an important global threat to individuals with …

Rationale: Estimating the annual incidence and prevalence of nontuberculous
mycobacterial (NTM) lung disease may assist in improving understanding of the public …

Population-based data have documented a continued increase in NTM prevalence since
2000. Annual prevalence in North American and Australia ranges from 3.2–9.8 per 100,000 …

Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can
cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory …

Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

Pulmonary infections due to nontuberculous mycobacteria (NTM) are increasingly
recognized worldwide. Although over 150 different species of NTM have been described …

Background Increasing numbers of individuals with cystic fibrosis are becoming infected
with the multidrug-resistant non-tuberculous mycobacterium (NTM) Mycobacterium …